We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLorazepam dose-dependently decreases risk-taking related activation in limbic areas.AuthorsArce, Estibaliz; Miller, Daniel A; Feinstein, Justin S; Stein, Murray B; Paulus, Martin PAbstractSeveral studies have examined the role of different neurotransmitter systems in modulating risk-taking behavior.PublicationPsychopharmacology, 2006, Vol 189, Issue 1, p105ISSN0033-3158Publication typeJournal ArticleDOI10.1007/s00213-006-0519-8